Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4556-4556
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Lipid droplet biogenesis and functions in health and disease
Armella Zadoorian, Ximing Du, Hongyuan Yang
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 443-459
Open Access | Times Cited: 235
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 278-278
Open Access | Times Cited: 21
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Ahmed Samy, Mohamed A. Kandeil, Dina Sabry, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30387-e30387
Open Access | Times Cited: 13
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
Pegah Golabi, Soroor Owrangi, Zobair M. Younossi
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 13
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
Simona Cernea
Life (2024) Vol. 14, Iss. 2, pp. 272-272
Open Access | Times Cited: 8
Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis
Dachuan Jin, Shunqin Jin, Tao Zhou, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 5
Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
Hao‐Kai Chen, Jing Luo, Xiujuan Li, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
Yijie Li, Brittney O. Baumert, Nikos Stratakis, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 4, pp. 332-345
Open Access | Times Cited: 5
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe
Molecules (2024) Vol. 29, Iss. 3, pp. 709-709
Open Access | Times Cited: 5
Association between serum trace element, mineral, and amino acid levels with non-alcoholic fatty liver disease (NAFLD) in adult women
Alexey A. Tinkov, Tatiana V. Korobeinikova, G.D. Morozova, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 83, pp. 127397-127397
Closed Access | Times Cited: 4
Association Between Sociodemographic Variables, Healthy Habits, and Stress with Risk Scales for Liver Disease Associated with Metabolic Dysfunction
Ángel Arturo López‐González, Emilio Martínez-Almoyna Rifá, Hernán Paublini, et al.
Life (2025) Vol. 15, Iss. 1, pp. 116-116
Open Access
Disparities in Alcohol‐Associated Liver Disease Hospital Encounters Amongst a Texas‐Based Cohort of Patients
Thomas G. Cotter, Ahmad Anouti, Bill Zhang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
Maria V. Bourganou, Maria Chondrogianni, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1589-1589
Open Access
Outcomes in Acute Decompensated Congestive Heart Failure Admissions with Chronic Liver Disease: A Nationwide Analysis Using the National Inpatient Sample
Vivek Joseph Varughese, Vignesh Krishnan Nagesh, Pratiksha Moliya, et al.
Medical Sciences (2025) Vol. 13, Iss. 1, pp. 19-19
Open Access
Association of Serum Uric Acid-to-Creatinine Ratio with Non-Alcoholic Fatty Liver Disease in the Population of Sargodha
Saima Rasheed, Amina Shahid, Abubakar Sarfraz, et al.
Pakistan Journal of Health Sciences (2025), pp. 359-364
Closed Access
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus
Biomedicines (2022) Vol. 11, Iss. 1, pp. 106-106
Open Access | Times Cited: 19
The association of systemic inflammatory biomarkers with non-alcoholic fatty liver disease: a large population-based cross-sectional study
Wu Sun, Fang Yan, Bing Zhou, et al.
Preventive Medicine Reports (2023) Vol. 37, pp. 102536-102536
Open Access | Times Cited: 9
Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population
Nehal Elmansoury, Ahmed A. Megahed, Ahmed Kamal, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 455-455
Open Access | Times Cited: 3
Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
Takahiro Kodama, Tetsuo Takehara
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 147-158
Open Access | Times Cited: 2
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction
Stefano Ciardullo, Gianluca Perseghin
Metabolism and Target Organ Damage (2024)
Open Access | Times Cited: 2
Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases
Xinyue Jiang, Hongzhan Wang, Kexin Nie, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood
Jasmin de Groot, Susana Santos, Madelon L. Geurtsen, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102248-102248
Open Access | Times Cited: 6
Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study
Joseph Gosnell, George Golovko, Esteban Arroyave, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 5, pp. 886-897
Open Access | Times Cited: 1
Environmental, Metabolic, and Nutritional Factors Concerning Dementia in African-Americans and Hispanic Populations
Arnold R. Eiser
The American Journal of Medicine (2024) Vol. 137, Iss. 10, pp. 939-942
Closed Access | Times Cited: 1
Impact of Physical Activity on Overall Survival and Liver Cirrhosis Incidence in Steatotic Liver Disease: Insights from a Large Cohort Study Using Inverse Probability of Treatment Weighting
Keungmo Yang, Beom Sun Chung, Tom Ryu
Nutrients (2024) Vol. 16, Iss. 15, pp. 2532-2532
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top